Phase1/‐2 study of Pomalidomide in myelofibrosis
2009; Wiley; Volume: 85; Issue: 2 Linguagem: Inglês
10.1002/ajh.21598
ISSN1096-8652
AutoresRuben A. Mesa, Animesh Pardanani, Kebede Hussein, Wenting Wu, Susan M. Schwager, Mark R. Litzow, William J. Hogan, Ayalew Tefferi,
Tópico(s)Acute Myeloid Leukemia Research
ResumoAmerican Journal of HematologyVolume 85, Issue 2 p. 129-130 LetterFree Access Phase1/-2 study of Pomalidomide in myelofibrosis† Ruben A. Mesa, Corresponding Author Ruben A. Mesa mesa.ruben@mayo.edu Hematology and Oncology, Mayo Clinic, Scottsdale, ArizonaProfessor of Medicine, Consultant of Hematology and Oncology, Mayo Clinic, 13400 E. Shea BLVD, Scottsdale 85259, AZSearch for more papers by this authorAnimesh D. Pardanani, Animesh D. Pardanani Hematology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this authorKebede Hussein, Kebede Hussein Hematology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this authorWenting Wu, Wenting Wu Cancer Center Biostatistics, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this authorSusan Schwager, Susan Schwager Hematology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this authorMark R. Litzow, Mark R. Litzow Hematology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this authorWilliam J Hogan, William J Hogan Hematology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this authorAyalew Tefferi, Ayalew Tefferi Hematology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this author Ruben A. Mesa, Corresponding Author Ruben A. Mesa mesa.ruben@mayo.edu Hematology and Oncology, Mayo Clinic, Scottsdale, ArizonaProfessor of Medicine, Consultant of Hematology and Oncology, Mayo Clinic, 13400 E. Shea BLVD, Scottsdale 85259, AZSearch for more papers by this authorAnimesh D. Pardanani, Animesh D. Pardanani Hematology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this authorKebede Hussein, Kebede Hussein Hematology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this authorWenting Wu, Wenting Wu Cancer Center Biostatistics, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this authorSusan Schwager, Susan Schwager Hematology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this authorMark R. Litzow, Mark R. Litzow Hematology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this authorWilliam J Hogan, William J Hogan Hematology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this authorAyalew Tefferi, Ayalew Tefferi Hematology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this author First published: 18 November 2009 https://doi.org/10.1002/ajh.21598Citations: 15 † Conflict of interest: Nothing to report. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume85, Issue2February 2010Pages 129-130 This article also appears in:AJH "Top 40" 40th Anniversary Collection.Ayalew Tefferi, MD - 2016 Henry M. Stratton Medal for Clinical/Translational Research Award Recipient ReferencesRelatedInformation
Referência(s)